Jazz Pharmaceuticals PLC (JAZZ)
Quick ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 1,506,310 | 1,335,690 | 1,282,300 | 1,167,910 | 881,482 | 839,358 | 711,265 | 490,835 | 591,448 | 671,780 | 891,400 | 2,097,530 | 1,057,770 | 741,942 | 786,082 | 701,602 | 637,344 | 795,175 | 637,739 | 547,466 |
| Short-term investments | US$ in thousands | 420,000 | 250,000 | 80,000 | 180,000 | 30,000 | 60,000 | 60,000 | — | — | — | — | 335,000 | 1,075,000 | 1,175,000 | 910,000 | 280,000 | 440,000 | 275,000 | 245,000 | 285,000 |
| Receivables | US$ in thousands | 705,794 | 627,841 | 610,389 | 623,938 | 651,493 | 601,179 | 594,034 | 572,392 | 563,360 | 499,023 | 506,660 | 413,976 | 396,490 | 361,664 | 351,920 | 317,301 | 355,987 | 267,031 | 311,249 | 320,485 |
| Total current liabilities | US$ in thousands | 1,536,690 | 1,573,330 | 945,265 | 908,902 | 933,193 | 812,954 | 705,442 | 737,409 | 809,303 | 735,053 | 880,588 | 752,093 | 653,745 | 642,133 | 409,960 | 396,123 | 364,490 | 390,439 | 369,493 | 413,999 |
| Quick ratio | 1.71 | 1.41 | 2.09 | 2.17 | 1.67 | 1.85 | 1.94 | 1.44 | 1.43 | 1.59 | 1.59 | 3.78 | 3.87 | 3.55 | 5.00 | 3.28 | 3.93 | 3.42 | 3.23 | 2.78 |
December 31, 2023 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($1,506,310K
+ $420,000K
+ $705,794K)
÷ $1,536,690K
= 1.71
The quick ratio measures a company's ability to meet its short-term obligations using its most liquid assets. A higher quick ratio indicates a stronger ability to cover immediate liabilities.
Analyzing Jazz Pharmaceuticals plc's quick ratio over the past eight quarters shows some fluctuations. The company maintained a healthy quick ratio above 1.5 in all quarters, indicating a good ability to meet short-term obligations. The ratio peaked at 2.49 in Q2 2023, suggesting a strong liquidity position at that time.
However, the quick ratio showed some inconsistency, with fluctuations between 1.67 and 2.49. While the ratio was generally above 2 in 2022, it dropped below that level in Q3 2023 and Q4 2023. This could indicate either a decrease in liquid assets or an increase in short-term obligations during those quarters.
Overall, while fluctuations occurred, Jazz Pharmaceuticals plc's quick ratio consistently remained at healthy levels, suggesting a relatively stable liquidity position during the period analyzed.
Peer comparison
Dec 31, 2023